Russell Investments Group, Ltd. Iovance Biotherapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

  • $66.8 Billion
  • Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 7,268 shares of IOVA stock, worth $59,161. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,268
Previous 22,000 66.96%
Holding current value
$59,161
Previous $176,000 61.36%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$7.28 - $11.9 $107,248 - $175,310
-14,732 Reduced 66.96%
7,268 $68,000
Q2 2024

Aug 08, 2024
BUY
$7.78 - $14.19 $164,663 - $300,331
21,165 Added 2534.73%
22,000 $176,000
Q1 2024

May 08, 2024
SELL
$7.59 - $17.47 $54,648 - $125,783
-7,200 Reduced 89.61%
835 $12,000
Q4 2023

Feb 05, 2024
SELL
$3.3 - $8.89 $17,440 - $46,983
-5,285 Reduced 39.68%
8,035 $65,000
Q3 2023

Nov 13, 2023
SELL
$4.44 - $8.79 $52,298 - $103,537
-11,779 Reduced 46.93%
13,320 $60,000
Q2 2023

Aug 10, 2023
SELL
$5.36 - $9.06 $758,434 - $1.28 Million
-141,499 Reduced 84.93%
25,099 $176,000
Q1 2023

May 09, 2023
BUY
$5.53 - $8.22 $671,563 - $998,236
121,440 Added 268.92%
166,598 $1.02 Million
Q4 2022

Feb 08, 2023
BUY
$5.62 - $10.0 $144,720 - $257,510
25,751 Added 132.69%
45,158 $288,000
Q3 2022

Nov 04, 2022
SELL
$9.53 - $13.11 $61,535 - $84,651
-6,457 Reduced 24.97%
19,407 $184,000
Q2 2022

Jul 29, 2022
BUY
$6.38 - $18.33 $159,685 - $458,781
25,029 Added 2997.49%
25,864 $284,000
Q1 2022

May 05, 2022
BUY
$12.38 - $19.1 $10,337 - $15,948
835 New
835 $13,000
Q3 2021

Nov 08, 2021
SELL
$20.35 - $26.63 $225,335 - $294,873
-11,073 Closed
0 $0
Q2 2021

Aug 04, 2021
SELL
$16.33 - $33.07 $168,052 - $340,323
-10,291 Reduced 48.17%
11,073 $287,000
Q1 2021

May 10, 2021
BUY
$28.67 - $52.59 $298,741 - $547,987
10,420 Added 95.21%
21,364 $675,000
Q3 2020

Nov 09, 2020
SELL
$27.75 - $36.3 $1.4 Million - $1.84 Million
-50,630 Reduced 82.23%
10,944 $360,000
Q2 2020

Aug 05, 2020
SELL
$27.21 - $41.0 $628,959 - $947,715
-23,115 Reduced 27.29%
61,574 $1.69 Million
Q1 2020

May 06, 2020
SELL
$19.54 - $38.85 $3,575 - $7,109
-183 Reduced 0.22%
84,689 $2.53 Million
Q4 2019

Jan 29, 2020
BUY
$17.95 - $29.41 $655,534 - $1.07 Million
36,520 Added 75.53%
84,872 $2.35 Million
Q3 2019

Nov 01, 2019
BUY
$17.99 - $26.0 $869,852 - $1.26 Million
48,352 New
48,352 $880,000
Q4 2017

Feb 06, 2018
SELL
$6.65 - $9.25 $111,267 - $154,771
-16,732 Closed
0 $0
Q3 2017

Nov 07, 2017
BUY
$4.45 - $8.55 $74,457 - $143,058
16,732
16,732 $130,000

Others Institutions Holding IOVA

# of Institutions
313
Shares Held
241M
Call Options Held
3.77M
Put Options Held
1.7M
View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

IOVA Quotes by TradingView
  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.28B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email